A new clinical trial published in Cell Metabolism indicates that a ketogenic diet offers metabolic advantages that extend well beyond simple weight loss. Researchers at Washington University School of Medicine in St. Louis found that participants on a very low-carbohydrate, high-fat diet experienced a 67% reduction in liver fat over four to five months. This result significantly outperformed both Mediterranean and low-fat diet groups, despite all three groups losing similar amounts of body weight.
Keto Diet Liver Fat Reduction Outpaces Other Diets
The study involved 42 adults with obesity, prediabetes, and fatty liver disease. Participants were randomly assigned to one of three dietary plans: ketogenic, Mediterranean, or a plant-forward low-fat diet. To ensure strict adherence, the research team provided all meals and held weekly consultations with dietitians. Calorie intake was individually adjusted so that every participant lost approximately 10% of their starting body weight, a target reached in about four to five months.
While all groups showed improvements in insulin sensitivity and body fat, the ketogenic group demonstrated superior outcomes in liver health. The keto diet restricted carbohydrates to just 4% of daily calories while deriving 73% of calories from fat. In contrast, the Mediterranean diet provided 50% of calories from carbohydrates and 35% from fat, while the low-fat group consumed 70% of calories from carbohydrates and only 15% from fat.
Participants on the ketogenic diet saw their liver fat drop by an average of 67%. Those on the Mediterranean and low-fat diets experienced a 45% reduction in liver fat. Because the weight loss was comparable across all groups, the researchers concluded that carbohydrate restriction influences liver fat through mechanisms independent of weight reduction alone.
Prediabetes Reversal and Hormonal Changes
The benefits of the ketogenic approach were particularly striking for participants with prediabetes, a condition where blood sugar levels are elevated but not yet high enough to diagnose type 2 diabetes. After the four-to-five-month intervention, approximately 50% of the keto group no longer met the diagnostic criteria for prediabetes. By comparison, 29% of the Mediterranean group and only 7% of the low-fat group achieved this milestone.
Researchers analyzed blood samples collected over 24-hour periods to understand the hormonal drivers behind these results. The ketogenic group showed the largest increase in glucagon, a hormone that helps regulate energy supply and promotes the breakdown of fat stored in the liver. Simultaneously, these participants experienced the largest decrease in insulin levels, a change that helps reduce the accumulation of fat in liver cells.

One unexpected finding was that participants consuming nearly three-quarters of their calories from fat did not experience an increase in blood fat or cholesterol levels. Max Petersen, the study’s first author, noted that this lack of negative impact on blood lipids was surprising given the high intake of dietary fat, which can include saturated fats from animal products.
Implications for Metabolic Health and Obesity Treatment
Samuel Klein, the study’s corresponding author, emphasized that while weight loss is known to improve metabolic health in obese individuals, the composition of the diet plays a critical role. He stated that reducing carbohydrate intake can have important therapeutic effects on metabolism for those with high liver fat and prediabetes, beyond just the effects of losing pounds.
The findings come as powerful new obesity treatments, such as GLP-1 medications, become more widely available. Petersen pointed out that while these drugs have revolutionized obesity therapy by enabling significant weight loss, dietary composition can provide additional metabolic benefits. The study suggests that specific dietary choices can influence how the body handles blood sugar and stores fat, even when weight loss is similar.
The trial was relatively small and short-term, so longer studies with more participants are needed to determine if these benefits persist over time. The research was supported by the National Institutes of Health and the Foundation for Barnes-Jewish Hospital.
Source: ScienceDaily

